# FDA Inspection 1094252 - Sanford Bismarck - June 04, 2019

Source: https://www.keypedia.com/records/fda_inspections/sanford-bismarck/e66106e7-3cff-4934-adaf-d67bd992113f
Source feed: FDA_Inspections

> FDA Inspection 1094252 for Sanford Bismarck on June 04, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094252
- Company Name: Sanford Bismarck
- Inspection Date: 2019-06-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258132 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/sanford-bismarck/450e3141-9194-4696-90a9-67b5781055cc)
- [FDA Inspection 1258132 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/sanford-bismarck/23bde5fe-ccdd-4b8c-b423-9e9714096beb)
- [FDA Inspection 1013079 - 2017-05-24](https://www.keypedia.com/records/fda_inspections/sanford-bismarck/14374774-6269-42f8-b2ec-3e70309177ad)

Company: https://www.keypedia.com/companies/sanford-bismarck/0f10dc03-4295-4487-947b-a3a40d839e13

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d